Terns Pharmaceuticals Inc
TERN
Mkt cap
$6.12B
EV/Sales
N/A
P/E ratio
N/A
FY2022 Revenue
N/A
EPS (qtr ended 2025-09-30)
$-0.27
Gross Margin (FY2022)
N/A
Profit Margin (FY2022)
N/A
Beta
N/A
Div yield
N/A
Sector
Healthcare
Terns Pharmaceuticals Inc (TERN) is a biotechnology company listed on NASDAQ.
Latest reported TERN revenue for 2022-12-31 was $0. Net income was -$60.3M. Revenue was down 100.0% from 2021-12-31 to 2022-12-31. TERN currently screens at market cap $6.12B.
Use this TERN research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full TERN income, balance, and cash tables.
Terns Pharmaceuticals Inc (TERN) is a biotechnology company in the Healthcare sector.
Latest cached Terns Pharmaceuticals Inc (TERN) net income for Dec 31, 2022 was -$60.3M. Statements: https://lician.com/financials/tern
Terns Pharmaceuticals Inc (TERN) market capitalization is $6.12B on the latest cached snapshot.
The latest cached TERN filing is 8-K · Jan 9, 2026. Filings: https://lician.com/sec/tern